2020
Exploring supervised machine learning approaches to predicting Veterans Health Administration chiropractic service utilization
Coleman BC, Fodeh S, Lisi AJ, Goulet JL, Corcoran KL, Bathulapalli H, Brandt CA. Exploring supervised machine learning approaches to predicting Veterans Health Administration chiropractic service utilization. Chiropractic & Manual Therapies 2020, 28: 47. PMID: 32680545, PMCID: PMC7368704, DOI: 10.1186/s12998-020-00335-4.Peer-Reviewed Original ResearchConceptsSpinal pain conditionsService utilizationPain conditionsChiropractic careConservative interventionsChiropractic servicesVA chiropractic servicesRetrospective cohort studyHealthcare service utilizationHealthcare cost burdenLimited clinical utilityLower healthcare costsCohort entryCohort studyDiagnosis cohortPain statusPrimary outcomeChiropractic visitsClinical featuresUS adultsClinical utilityHealthcare costsDifferent clinical populationsVisitsClinical populations
2014
The VACS Index Accurately Predicts Mortality and Treatment Response among Multi-Drug Resistant HIV Infected Patients Participating in the Options in Management with Antiretrovirals (OPTIMA) Study
Brown ST, Tate JP, Kyriakides TC, Kirkwood KA, Holodniy M, Goulet JL, Angus BJ, Cameron DW, Justice AC, . The VACS Index Accurately Predicts Mortality and Treatment Response among Multi-Drug Resistant HIV Infected Patients Participating in the Options in Management with Antiretrovirals (OPTIMA) Study. PLOS ONE 2014, 9: e92606. PMID: 24667813, PMCID: PMC3965438, DOI: 10.1371/journal.pone.0092606.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsAgedBiomarkersDrug Resistance, Multiple, ViralFollow-Up StudiesHIV InfectionsHumansMaleMiddle AgedModels, BiologicalPredictive Value of TestsRisk FactorsConceptsVACS IndexCombination antiretroviral therapyNet reclassification improvementHIV biomarkersCause mortalityC-statisticTreatment interventionsMulti-drug resistant HIVHarrel's c-statisticsRespective hazard ratiosKaplan-Meier estimatesProportional hazards modelImproved scoresAntiretroviral studiesAntiretroviral therapyHazard ratioResistant HIVReclassification improvementRestricted IndexTreatment responseStudy interventionRisk scoreHazards modelVAC indexMortality